Hims & Hers Health (HIMS) Stock Forecast & Price Target
HIMS Analyst Ratings
Hold
3Buy11Hold0Sell
Based on 14 analysts giving stock ratings to Hims & Hers Health in the past 3 months
HIMS Stock 12 Month Forecast
Average Price Target
MXN 612.47▲(18.24% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is MXN 612.47 with a high forecast of MXN 783.83 and a low forecast of MXN 485.23. The average price target represents a 18.24% change from the last price of MXN 518.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 783.83
AverageMXN 612.47
LowMXN 485.23
Highest Price TargetHighestMXN 783.83Average Price TargetMXN 612.47Lowest Price TargetLowestMXN 485.23
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Glen Santangelo | Barclays | MXN 653.19 | buy | 26.10%Upside | Reiterated | 10/29/26 | ||
| Allen Lutz | Bank of America Securities | MXN 597.20 | hold | 15.29%Upside | Reiterated | 10/28/26 | ||
| Bryan Smilek | J.P. Morgan | MXN 597.20 | hold | 15.29%Upside | Initiated | 09/11/26 | ||
| Jailendra Singh | Truist Financial | MXN 597.20 | hold | 15.29%Upside | Reiterated | 09/11/26 | ||
| Brian Tanquilut | Jefferies | MXN 578.54 | hold | 11.69%Upside | Reiterated | 09/03/26 | ||
| Justin Patterson | KeyBanc | ― | hold | ― | Reiterated | 09/02/26 | ||
| Daniel Grosslight | Citi | MXN 653.19→MXN 615.87 | hold | 18.89%Upside | Reiterated | 08/12/26 | ||
| Mark Mahaney | Evercore ISI | ― | hold | ― | Reiterated | 08/11/26 | ||
| David Larsen | BTIG | ― | hold | ― | Assigned | 08/11/26 | ||
| Ryan MacDonald | Needham | MXN 653.19→MXN 783.83 | buy | 51.32%Upside | Reiterated | 08/11/26 | ||
| Maria Ripps | Canaccord Genuity | MXN 746.51 | buy | 44.11%Upside | Reiterated | 08/11/26 | ||
| Craig Hettenbach | Morgan Stanley | MXN 391.92→MXN 522.55 | hold | 0.88%Upside | Assigned | 08/11/26 | ||
| Jonna Kim | TD Cowen | MXN 466.57→MXN 559.88 | hold | 8.08%Upside | Assigned | 08/11/26 | ||
| George Hill | Deutsche Bank | MXN 466.57→MXN 485.23 | hold | -6.33%Downside | Assigned | 08/11/26 | ||
| Michael Cherny | Leerink Partners | ― | hold | ― | Reiterated | 04/16/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Glen Santangelo | 10/29/26 | MXN 653.19 | buy | 26.10%Upside | Reiterated | Barclays | ||
| Allen Lutz | 10/28/26 | MXN 597.20 | hold | 15.29%Upside | Reiterated | Bank of America Securities | ||
| Bryan Smilek | 09/11/26 | MXN 597.20 | hold | 15.29%Upside | Initiated | J.P. Morgan | ||
| Jailendra Singh | 09/11/26 | MXN 597.20 | hold | 15.29%Upside | Reiterated | Truist Financial | ||
| Brian Tanquilut | 09/03/26 | MXN 578.54 | hold | 11.69%Upside | Reiterated | Jefferies | ||
| Justin Patterson | 09/02/26 | ― | hold | ― | Reiterated | KeyBanc | ||
| Daniel Grosslight | 08/12/26 | MXN 653.19→MXN 615.87 | hold | 18.89%Upside | Reiterated | Citi | ||
| Mark Mahaney | 08/11/26 | ― | hold | ― | Reiterated | Evercore ISI | ||
| David Larsen | 08/11/26 | ― | hold | ― | Assigned | BTIG | ||
| Ryan MacDonald | 08/11/26 | MXN 653.19→MXN 783.83 | buy | 51.32%Upside | Reiterated | Needham | ||
| Maria Ripps | 08/11/26 | MXN 746.51 | buy | 44.11%Upside | Reiterated | Canaccord Genuity | ||
| Craig Hettenbach | 08/11/26 | MXN 391.92→MXN 522.55 | hold | 0.88%Upside | Assigned | Morgan Stanley | ||
| Jonna Kim | 08/11/26 | MXN 466.57→MXN 559.88 | hold | 8.08%Upside | Assigned | TD Cowen | ||
| George Hill | 08/11/26 | MXN 466.57→MXN 485.23 | hold | -6.33%Downside | Assigned | Deutsche Bank | ||
| Michael Cherny | 04/16/26 | ― | hold | ― | Reiterated | Leerink Partners |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Hims & Hers Health
3 Months
Success Rate11/16 ratings generated profit
69%
Average Return
+22.23%
Copying Maria Ripps's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +22.23% per trade.
1 Year
Success Rate8/13 ratings generated profit
62%
Average Return
+25.01%
Copying Glen Santangelo's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +25.01% per trade.
2 Years
Success Rate8/13 ratings generated profit
62%
Average Return
+25.88%
Copying Glen Santangelo's trades and holding each position for 2 Years would result in 61.54% of your transactions generating a profit, with an average return of +25.88% per trade.
HIMS Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 8 | 10 | 9 | 7 | 5 |
| Hold | 21 | 25 | 22 | 27 | 18 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 29 | 35 | 31 | 34 | 23 |
In the current month, HIMS has received 5 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. HIMS average Analyst price target in the past 3 months is 612.47.
HIMS Financial Forecast
HighMXN 3.76
ConsensusMXN 1.07
LowMXN -0.94
HIMS Earnings Forecast
Next quarter’s earnings estimate for HIMS is MXN 1.07 with a range of -MXN 0.94 to MXN 3.76. The previous quarter’s EPS was -MXN 6.95. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 16.9B
ConsensusMXN 16.8B
LowMXN 16.6B
HIMS Sales Forecast
Next quarter’s sales forecast for HIMS is MXN 16.78B with a range of MXN 16.61B to MXN 16.94B. The previous quarter’s sales results were MXN 14.15B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
HIMS Stock Forecast FAQ
What is MX:HIMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is Mex$612.47.
What is MX:HIMS’s upside potential, based on the analysts’ average price target?
Hims & Hers Health has 18.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hims & Hers Health a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Hold, which is based on 3 buy ratings, 11 hold ratings and 0 sell ratings.
What is Hims & Hers Health’s share price target?
The average share price target for Hims & Hers Health is Mex$612.47. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$783.83, and the lowest forecast is Mex$485.23. The average share price target represents a 18.24% increase from the current price of Mex$518.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Hims & Hers Health?
To buy shares of MX:HIMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
